Lipodystrophy comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-03. Numbers and descriptions here follow the published literature rather than marketing material.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Enantiopure compounds consist of only one of the two enantiomers. Enantiopurity is of practical importance since such compositions have improved therapeutic efficacy. The switch from a racemic drug to an enantiopure drug is called a chiral switch. In many cases, the enantiomers have distinct effects. One case is that of Propoxyphene. The enantiomeric pair of propoxyphene is separately sold by Eli Lilly and company. One of the partners is dextropropoxyphene, an analgesic agent (Darvon) and the other is called levopropoxyphene, an effective antitussive (Novrad). It is interesting to note that the trade names of the drugs, DARVON and NOVRAD, also reflect the chemical mirror-image relationship. In other cases, there may be no clinical benefit to the patient. In some jurisdictions, single-enantiomer drugs are separately patentable from the racemic mixture. It is possible that only one of the enantiomers is active. Or, it may be that both are active, in which case separating the mixture has no objective benefits, but extends the drug's patentability.
== History == Efficacy was evaluated in RAMP-201 (NCT04625270), an open-label, multi-center trial that included 57 adult participants with measurable KRAS-mutated recurrent low-grade serous ovarian cancer. Participants were required to have received at least one prior systemic therapy, including a platinum-based regimen. KRAS mutation status was determined by prospective local testing of tumor tissue. Participants received avutometinib 3.2 mg orally twice weekly and defactinib 200 mg orally twice daily, both taken for the first 3 weeks of each 4-week cycle until disease progression or unacceptable toxicity.
At this point, a fully working vaccine has not been created, and it is therefore decided that the best thing for the Syndicate to do is to comply with the original deal and turn over the hybrid to the Colonists in the hope that they are spared the resulting takeover. Before this can be done, however, the Rebels kill all but a few members of the Syndicate in addition to Cassandra, the only living successful alien-human hybrid, before the Syndicate is able to send a signal to the Colonists. Without a successful hybrid, the timetable for the Colonist invasion will not be advanced and the date set for colonization remains December 22, 2012.
=== Mechanical bonding effects on chemical reactivity === The mechanical bond can reduce the kinetic reactivity of the products, this is ascribed to the increased steric hindrance. Because of this effect hydrogenation of an alkene on the thread of a rotaxane is significantly slower as compared to the equivalent non interlocked thread. This effect has allowed for the isolation of otherwise reactive intermediates. The ability to alter reactivity without altering covalent structure has led to MIMAs being investigated for a number of technological applications.
Sources: en.wikipedia.org
==== MeSH D12.776.964.950.800 – trans-activators ==== MeSH D12.776.964.950.800.385 – gene products, rev (HIV) MeSH D12.776.964.950.800.400 – gene products, tat MeSH D12.776.964.950.800.410 – gene products, tax MeSH D12.776.964.950.800.430 – gene products, vpr MeSH D12.776.964.950.800.445 – herpes simplex virus protein vmw65
=== Therapeutic effects === Pain relief: Primarily, fentanyl provides the relief of pain by acting on the brain and spinal μ-receptors. Sedation: Fentanyl produces sleep and drowsiness, as the dosage is increased, and can produce the δ-waves often seen in natural sleep on electroencephalogram. Suppression of the cough reflex: Fentanyl can decrease the struggle against an endotracheal tube and excessive coughing by decreasing the cough reflex, becoming useful when intubating people who are awake and have compromised airways. After receiving a bolus dose of fentanyl, people can also experience paradoxical coughing, which is a phenomenon that is not well understood.
== Organization and administration == The University of Arizona, like its sister institutions Arizona State University and Northern Arizona University, is governed by the Arizona Board of Regents or the ABOR, a 12-member body. Eight volunteer members are appointed by the Governor to staggered eight-year terms; two students serve on the board for two-year appointments, with the first year being a nonvoting apprentice year. The Governor and the Superintendent of Public Instruction serve as voting ex-officio members. The ABOR provides "policy guidance" and oversight to the three major degree-granting universities, as provided for by Title 15 of the Arizona Revised Statutes. Suresh Garimella was named the 23rd president of the U of A on August 9, 2024. Previously, he was the president of the University of Vermont from 2019 to 2024. Garimella has also previously served as the Executive Vice President for Research and Partnerships, a Chief Global Affairs Officer, and was recognized as a Goodson Distinguished Professor of Mechanical Engineering at Purdue University. Garimella replaced Robert C. Robbins, MD. He was named as the lone finalist to succeed as president after Robbins announced his plans to step down at the end of his current contract, or before if a suitable successor was identified, during an ABOR meeting on April 2, 2024.
Unattended weather station recording (such as wind speed / direction, temperature, relative humidity, solar radiation). Unattended hydrographic recording (such as water level, water depth, water flow, water pH, water conductivity). Unattended soil moisture level recording. Unattended gas pressure recording. Offshore buoys for recording a variety of environmental conditions. Road traffic counting. Measure temperatures (humidity, etc.) of perishables during shipments: Cold chain. Measure variations in light intensity. Measuring temperature of pharmaceutical products, medicines and vaccines during storage Measuring temperature and humidity of perishable products during transportation to ensure cold chain is maintained Process monitoring for maintenance and troubleshooting applications. Process monitoring to verify warranty conditions Wildlife research with pop-up archival tags Measure vibration and handling shock (drop height) environment of distribution packaging. Tank level monitoring. Deformation monitoring of any object with geodetic or geotechnical sensors controlled by an automatic deformation monitoring system. Environmental monitoring. Vehicle testing (including crash testing) Motor racing Monitoring of relay status in railway signaling. For science education enabling 'measurement', 'scientific investigation' and an appreciation of 'change' Record trend data at regular intervals in veterinary vital signs monitoring. Load profile recording for energy consumption management. Temperature, humidity and power use for heating and air conditioning efficiency studies.
The 1848 appointment of Lord Dalhousie as the Governor General of the East India Company set the stage for changes essential to a modern state: consolidating and demarcating sovereignty, monitoring the population through censuses, educating citizens and rationalising the beauraucracy. Technological advancements—among them, railways, canals, and the telegraph—were introduced within years of their introduction in Europe, with the East India Company guaranteeing fixed financial returns to attract British private investors. Simultaneously, the proponents of these public works lobbied the British government for support, presenting them as necessities for military logistics and security and Indian social and cultural reform. Thus, the Upper Doab's Ganges Canal—conceived by Proby Cautley under Lord Auckland and completed under Dalhousie—was promoted to Company's Court of Directors in London as both a vital relief response to the Agra famine of 1837–1838 and a revenue-generating irrigation and navigation project. The canal, which brought agricultural prosperity to some areas, ultimately caused soil salinisation in others. Disaffection with the company also grew during this time, culminating in the Indian Rebellion of 1857, which swept across the central Gangetic plain, and extended into Central India. Shaking the foundations of Company rule, the uprising was provoked by diverse resentments and perceptions, including invasive British-style social reforms, harsh land taxes, and summary treatment of some wealthy landowners and princes.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.